Covid-19. COVID-19 Disease
Conditions
Interventions
Intervention 1: Intervention group 1: Patients with Mild level of Covid-19 with vitamin D deficiency (less than 30 ng /ml). Intervention by taking routine medications in addition Consumption of vitami
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Being aged 20-70 years Hospitalization Positive polymerase chain reaction test (RT-PCR) No pre-existing already pneumonia, Chronic obstructive pulmonary diseas(COPD) and other respiratory illnesses No known chronic diseases (diabetes, hypertension, underlying heart disease, infectious, liver, kidney and epilepsy, neuromuscular, immune deficiency diseases and cancer) Not being hospitalized in the past month Do not have stressors such as the death of first-degree relatives, etc. in a recent month Not pregnant Do not use oral contraceptives, vitamin products, calcium, anticonvulsants, estrogen and diuretics Do not take injectable vitamin D in the last 6 months Lack of seasonal sensitivity
Exclusion criteria
Exclusion criteria: Dissatisfaction or obedience to the treatment to continue participating in the study Diagnosis of chronic diseases at the time of hospitalization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnosis and severity disease in patients with Covid 19. Timepoint: Determination of prognosis and severity disease in the beginning of the study (before the intervention) and 7, 14 days after the start of vitamin D intake. Method of measurement: Guidelines issued by the National Health Commission for the diagnosis and treatment of coronavirus. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayeh Nikkhah
Islamic Azad University
Outcome results
None listed